← Back to all trials
Not Yet Recruiting
NCT05755295
Feasibility and Acceptability of Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma
Conditions: Neuroblastoma
Sex: All
Ages: 10 Years – 26 Years
Phase: NA
Enrollment: 15
Sponsor: University Hospital, Toulouse
Summary
On average, each year in the former region, 60 new patients under the age of 18 are treated for a brain tumor, with an active post-treatment follow-up file of 350 patients.
Because of the significant sequelae induced by the disease or the treatments, these patients will very often require rehabilitative care.The interest of involving the horse in the population of patients cured of a medulloblastoma but with important physical and psychological after-effects is to be able to combine a therapy using animal mediation (equitherapy) and a rehabilitation therapy based on the three-dimensional movement of the horse (hippotherapy).
Eligibility Criteria
Inclusion Criteria:complete remission of medulloblastoma and after 5 years of the end of treatmentliving within 30 km away the riding center and/or less than 1 hour of transportinformed consentExclusion Criteria:Landsky score below 50% for minors until 16 years old and Karnofsky score below 50% for patients over 16 yearsmajor under juridical protection
Source: ClinicalTrials.gov (NCT05755295). StuddyBuddy aggregates publicly available trial information.